FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmacology and concerns the application of (S)-(+)-2-[4-(3-fluorobenzyloxy)benzylamino]propane amide in treating restless legs syndrome and addictive disorders.
EFFECT: invention provides high clinical effectiveness, essentially without side effects.
3 cl, 6 dwg, 4 tbl, 7 ex
Authors
Dates
2010-11-10—Published
2005-04-19—Filed